Jaguar health engages former fda gastroenterology division deputy director andrew mulberg, m.d. to bolster company's regulatory expertise

San francisco, ca / accesswire / january 30, 2023 / jaguar health, inc. (nasdaq:jagx) today announced that it has entered into a consulting agreement with andrew mulberg, m.d. to enhance the company's regulatory expertise.
JAGX Ratings Summary
Quant
JAGX Quant Ranking
Sector
Industry
Quant Rating
Quant Score